Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (5835)	1/3/1999 7:35:00 PM
From: Izzy	Read Replies (2) \| Respond to of 6136

FNS: Thanks for the reply. If you have time, look at the posts on Yahoo DD/MTC BBs. Several seem to think that DD will buyout MTC (apparently a long-standing rumor but appears to be more imminent now). To me it does matter since I've heard several times that DD has been interested in buying AGPH (no insider info). So I've been wondering if DD has the financial backing to buy both companies. In regards to stock price valuation in relationship to a potential buyout, AGPH, a smaller company, has a higher stock price than DD, a monster large company (maybe DD is undervalued). So would DD offer cash or stock buyout? Also, I've been waiting to buy AGPH again but certainly not at the present price (>58). So I've been trying to assess DD, MTC, and AGPH as to which ones will give a better ROI and, in 1999, they may end up being just one company. Guess I'm the only one addressing this issue. Perhaps it really isn't that important. We'll see.